Defining Endpoints in Becker Muscular Dystrophy
Defining Endpoints in Becker Muscular Dystrophy
Active, not recruiting · NCT05257473 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Defining Endpoints in Becker Muscular Dystrophy | Becker muscular dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Not stated | 2026-09-03 | NCT05257473 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Edgewise Therapeutics, Inc. | 6 |
| Virginia Commonwealth University | 122 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| John Walton Muscular Dystrophy Research Centre | Newcastle upon Tyne | United Kingdom | 1 |
| Kennedy Krieger Institute | Baltimore | United States | 41 |
| Nationwide Children's Hospital | Columbus | United States | 309 |
| University of Auckland | Auckland | New Zealand | 4 |
| University of California, Irvine | Orange | United States | 29 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Iowa | Iowa City | United States | 284 |
| University of Kansas Medical Center | Kansas City | United States | 240 |
| University of Minnesota | Minneapolis | United States | 325 |
| Virginia Commonwealth University | Richmond | United States | 156 |
| Washington University School of Medicine | St Louis | United States | 895 |